Clinical Study
Long-Term Effects and Prognosis in Acute Heart Failure Treated with Tolvaptan: The AVCMA Trial
Table 2
Comparisons of medications between the tolvaptan and carperitide groups at discharge.
| | | Tolvaptan | Carperitide | | | ( = 52) | ( = 53) |
| | Loop diuretics, (%) | 43 (83) | 44 (83) | | Thiazide diuretics, (%) | 4 (8) | 4 (7) | | Spironolactone, (%) | 29 (56) | 31 (58) | | -Blocker, (%) | 29 (56) | 33 (62) | | ACE inhibitors or ARBs, (%) | 26 (49) | 32 (60) | | Ca-Blocker, (%) | 9 (17) | 6 (11) |
|
|
ACE, angiotensin converting enzyme; ARB, angiotensin receptor blocker.
|
